| 2024-10-24 |
QEMLSHZS02762851 |
HIKMA PHARMACEUTICALS USA INC |
3227.0 kg |
330741
|
ORDER NO.PO5300055642 FOSAPREPITANT FOR INJ ECTION THIS SHIPMENT CONTAINS WOOD PACKING MATERIALS WHICH HAS BEEN FUMIGATED. |
| 2024-09-28 |
QEMLSHZS02734916 |
HIKMA PHARMACEUTICALS USA INC |
3256.0 kg |
854311
|
ORDER NO.5300055124 FOSAPREPITANT FOR INJECT ION 494CTNS=13PLTS |
| 2024-07-24 |
EXDO61N0853979 |
HIKMA PHARMACEUTICALS USA INC |
1634.0 kg |
848041
|
FOSAPREPITANT FOR INJECTION HTS: |
| 2024-07-24 |
EXDO61N0853978 |
HIKMA PHARMACEUTICALS USA INC |
1619.0 kg |
848041
|
FOSAPREPITANT FOR INJECTION HTS: |
| 2024-06-02 |
EXDO61N0845445 |
HIKMA PHARMACEUTICALS USA INC |
1613.0 kg |
848041
|
FOSAPREPITANT FOR INJECTION HTS: |
| 2024-04-17 |
EXDO61N0841615 |
HIKMA PHARMACEUTICALS USA INC |
1455.0 kg |
848041
|
FOSAPREPITANT FOR INJECTION HTS: |
| 2024-04-15 |
EXDO61N0844326 |
UPS SUPPLY CHAIN SOLUTIONS INC |
1400.0 kg |
848041
|
BORTEZOMIB FOR INJECTION HTS: |
| 2024-04-15 |
EXDO61N0844328 |
INGENUS PHARMACEUTICALS LLC |
330.0 kg |
848041
|
BORTEZOMIB FOR INJECTION HTS: |
| 2024-03-22 |
EXDO61N0839406 |
HIKMA PHARMACEUTICALS USA INC |
1570.0 kg |
848041
|
FOSAPREPITANT FOR INJECTION HTS: |
| 2024-03-22 |
EXDO61N0839783 |
HIKMA PHARMACEUTICALS USA INC |
1597.0 kg |
848041
|
FOSAPREPITANT FOR INJECTION HTS: |
| 2023-11-13 |
EXDO61N0823357 |
HIKMA PHARMACEUTICALS USA INC |
1374.0 kg |
848041
|
FOSAPREPITANT FOR INJECTION HTS: |
| 2023-10-09 |
EXDO61N0820985 |
UPS SUPPLY CHAIN SOLUTIONS INC |
1422.0 kg |
848041
|
BORTEZOMIB FOR INJECTION HTS: |
| 2023-09-24 |
EXDO61N0815630 |
HIKMA PHARMACEUTICALS USA INC |
1437.0 kg |
848041
|
FOSAPREPITANT FOR INJECTION HTS: |
| 2023-09-05 |
EXDO61N0814958 |
UPS SUPPLY CHAIN SOLUTIONS INC |
1426.0 kg |
848041
|
BORTEZOMIB FOR INJECTION HTS: |
| 2023-06-15 |
EXDO61N0803525 |
HIKMA PHARMACEUTICALS USA INC |
1456.0 kg |
848041
|
FOSAPREPITANT FOR INJECTION HTS: |
| 2023-06-15 |
EXDO61N0803520 |
HIKMA PHARMACEUTICALS USA INC |
1446.0 kg |
848041
|
FOSAPREPITANT FOR INJECTION HTS: |
| 2023-06-05 |
EXDO61N0802366 |
HIKMA PHARMACEUTICALS USA INC |
887.0 kg |
848041
|
FOSAPREPITANT FOR INJECTION HTS: |
| 2023-06-05 |
EXDO61N0802531 |
HIKMA PHARMACEUTICALS USA INC |
1460.0 kg |
848041
|
FOSAPREPITANT FOR INJECTION HTS: |
| 2023-05-23 |
EXDO61N0804216 |
HIKMA PHARMACEUTICALS USA INC |
1454.0 kg |
848041
|
BORTEZOMIB FOR INJECTION HTS: |
| 2023-04-01 |
EXDO61N0794486 |
HIKMA PHARMACEUTICALS USA INC |
1570.0 kg |
848041
|
FOSAPREPITANT FOR INJECTION HTS: |
| 2023-04-01 |
EXDO61N0794118 |
HIKMA PHARMACEUTICALS USA INC |
1519.0 kg |
848041
|
FOSAPREPITANT FOR INJECTION HTS: |
| 2023-02-05 |
EXDO61N0789948 |
EVERSANA LIFE SCIENCE SERVICES LLC |
1319.0 kg |
848041
|
BORTEZOMIB FOR INJECTION HTS: |
| 2023-01-02 |
EXDO61N0782642 |
HIKMA PHARMACEUTICALS USA INC |
1558.0 kg |
848041
|
FOSAPREPITANT FOR INJECTION HTS: |
| 2022-11-11 |
EXDO61N0779331 |
INTEGRATED COMMERCIALIZATION SOLUTI |
1352.0 kg |
848041
|
BORTEZOMIB FOR INJECTION HTS: |
| 2022-07-04 |
EXDO61N0755887 |
HIKMA PHARMACEUTICALS USA INC |
1567.0 kg |
848041
|
FOSAPREPITANT FOR INJECTION |
| 2022-07-04 |
EXDO61N0759384 |
APOTEX CORP |
1549.0 kg |
848041
|
FOSAPREPITANT FOR INJECTION |
| 2021-12-11 |
EXDO61N0721705 |
APOTEX CORP |
26344.0 kg |
848041
|
ONDANSETRON INJECTION (4MG/2ML) ONDANSETRON INJECTION (4MG/2ML) ONDANSETRON INJECTION (4MG/2ML) ONDANSETRON INJECTION (4MG/2ML) ONDANSETRON INJECTION (4MG/2ML) |
| 2021-07-17 |
EXDO61N0694787 |
APOTEX CORP |
10554.0 kg |
848041
|
ONDANSETRON INJECTION ( 4MG/2ML) ONDANSETRON INJECTION ( 4MG/2ML) |
| 2021-05-24 |
EXDO61N0694231 |
APOTEX CORP |
21069.0 kg |
848041
|
ONDANSETRON INJECTION ONDANSETRON INJECTION ONDANSETRON INJECTION ONDANSETRON INJECTION |
| 2021-04-21 |
EXDO61N0688831 |
APOTEX CORP |
15255.0 kg |
848041
|
ONDANSETRON INJECTION ( 4MG/2ML) (100MG/5ML) TEMPERATURE CONTROL:22 C IRINOTECAN HYDROCHLORIDE INJECTION |
| 2021-04-07 |
EXDO61N0687625 |
APOTEX CORP |
10492.0 kg |
848041
|
ONDANSETRON INJECTION ( 4MG/2ML) ONDANSETRON INJECTION ( 4MG/2ML) |
| 2021-03-31 |
EXDO61N0687023 |
APOTEX CORP |
9500.0 kg |
848041
|
ONDANSETRON INJECTION ( 4MG/2ML) PALONOSETRON HYDROCHLORIDE INJECTION |
| 2021-03-25 |
EXDO61N0694312 |
APOTEX CORP |
14420.0 kg |
848041
|
ONDANSETRON INJECTION ONDANSETRON INJECTION ONDANSETRON INJECTION |
| 2021-03-25 |
EXDO61N0686246 |
APOTEX CORP |
9341.0 kg |
848041
|
ONDANSETRON INJECTION ( 4MG/2ML) IRINOTECAN HYDROCHLORIDE INJECTION |
| 2021-03-12 |
EXDO61N0682562 |
HIKMA PHARMACEUTICALS USA INC |
1017.0 kg |
848041
|
FOSAPREPITANT FOR INJECTION |
| 2021-03-10 |
EXDO61N0684304 |
APOTEX CORP |
4187.0 kg |
848041
|
ONDANSETRON INJECTION ( 4MG/2ML) PALONOSETRON HYDROCHLORIDE INJECTION |
| 2021-02-15 |
EXDO61N0682171 |
APOTEX CORP |
15700.0 kg |
848041
|
ONDANSETRON INJECTION ( 4MG/2ML) ONDANSETRON INJECTION ( 4MG/2ML) ONDANSETRON INJECTION ( 4MG/2ML) |
| 2021-02-10 |
EXDO61N0681173 |
APOTEX CORP |
15510.0 kg |
848041
|
ONDANSETRON INJECTION ( 4MG/2ML) IRINOTECAN HYDROCHLORIDE INJECTION OXALIPLATIN INJECTION (50MG/10ML) |
| 2021-02-08 |
EXDO61N0676687 |
APOTEX CORP |
5610.0 kg |
848041
|
ONDANSETRON INJECTION ( 4MG/2ML) |
| 2021-01-07 |
EXDO61N0673007 |
APOTEX CORP |
15094.0 kg |
848041
|
ONDANSETRON INJECTION ( 4MG/2ML) IRINOTECAN HYDROCHLORIDE INJECTION OXALIPLATIN INJECTION (100MG/20ML) |
| 2020-11-09 |
EXDO61N0667325 |
APOTEX CORP |
9615.0 kg |
848041
|
IRINOTECAN HYDROCHLORIDE INJECTION OXALIPLATIN INJECTION IRINOTECAN HYDROCHLORIDE INJECTION ONDANSETRON INJECTION |
| 2020-11-09 |
EXDO61N0667326 |
APOTEX CORP |
10368.0 kg |
848041
|
ONDANSETRON INJECTION ONDANSETRON INJECTION |
| 2020-09-22 |
EXDO61N0657098 |
APOTEX CORP |
15698.0 kg |
848041
|
ONDANSETRON INJECTION ONDANSETRON INJECTION ONDANSETRON INJECTION |
| 2020-09-10 |
EXDO61N0654079 |
APOTEX CORP |
9502.0 kg |
848041
|
IRINOTECAN HYDROCHLORIDE INJECTION OXALIPLATIN INJECTION ONDANSETRON INJECTION |
| 2020-06-02 |
EXDO61N0636861 |
APOTEX CORP |
15591.0 kg |
848041
|
ONDANSETRON INJECTION (PHARMACEUTICAL PRODUCTS) ONDANSETRON INJECTION |